LY-2365109 is a glycine reuptake inhibitor. It is able to inhibit the type 1 glycine transporter. This inhibition increases extracellular levels of glycine. LY-2365109 has been shown to increase the seizure threshold in mice, meaning that this drug has potential as an anticonvulsant.
References